Agile Capital Markets

New deal Agile Capital Markets: Cilcare completes €40 Million Series A to Accelerate Development of Innovative Treatments for Early Hearing Loss. More information on: https://lnkd.in/djE5aUi9 #biotech #hearingdisorder #ai #synaptopathy #frenchtech #fundraising #investmentbanking

✨ We’re excited to unveil our new website! A fresh look, the same spirit: Agile Capital Markets remains a healthcare investment bank with a team of former healthcare CEOs/CFOs and VC/PE analysts, all with a dual background in healthcare and finance. This new identity reflects our expertise and commitment: creating new opportunities for our clients to maximize their odds of success and the value of their assets. 👉 https://lnkd.in/ecda7_MX 📩 contact@agilecapitalmarkets.com

Agile Capital Markets has served as a financial advisor to Discure Technologies on its $16 million Series A round. Funds will advance the clinical testing of Discure's breakthrough device for degenerative disc disease. Congratulations to Yuval Mandelbaum, and the rest of the Discure Technologies team for this well-deserved achievement! More information on : https://lnkd.in/dsXWg7SB #medtech #spine #DDD #fundraising #investmentbanking

Agile Capital Markets has served as the exclusive financial advisor to Cilcare on its exclusive option agreement for innovative hearing disorder treatments with Shionogi & Co., Ltd. Under the terms of the agreement: - Cilcare will receive an upfront payment of €15 million - Cilcare is eligible to receive up to €400 million in milestone payments upon successful development and commercialization of the drug candidates Congratulations to Celia Belline, Jérome Geoffroy and the rest of the Cilcare team! More information on https://lnkd.in/eDXzz4wi #biotech #hearingdisorder #ai #synaptopathy #frenchtech #fundraising #investmentbanking

Agile Capital Markets has served as the exclusive financial advisor to BIOPHTA, France-based pre-clinical stage company, developing a new standard or care for several eye diseases. Congratulations to Jean GARREC, Jean Cuiné and the rest of the Biophta team! More information on: https://lnkd.in/eDUdhgDX #biotech #ophthalmology #frenchtech #fundraising #investmentbanking

📢 Agile Capital Markets is thrilled to announce the promotion of Morgane Bonnevay to Vice President Healthcare. 🎉   “Over the last year, Morgane has been instrumental in several international transactions including buy side M&A mandates, fundraising and licensing deals. We are very happy to announce Morgane as Vice President.” Eric Cohen and Sophie Baratte, Partners.

📢 Agile Capital Markets is hiring its next cohort of interns. Join us! 🙂 - Background in Life Sciences (MD, PharmD, PhD, Engineer) and Corporate Finance (MiM, MSc) – gap year internship welcome. - Early work experience and proficiency in English required - Paris based - Competitive salary and bonus hr@agilecapitalmarkets.com #investmentbanking #fundraising #mergersacquisitions #biotech #medtech #digitalhealth